MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1266.41%
Quick Ratio
1266.41%
Cash Ratio
1144.38%
Debt to Asset Ratio
15.03%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Research and development incenti...
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Deferred revenue, net of current...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
559,474 628,110 648,325 721,451
Prepaid expenses and other current assets
18,744 19,181 23,231 22,058
Research and development incentives receivable
40,917 35,594 67,263 60,753
Total current assets
619,135 682,885 738,819 804,262
Property and equipment, net
5,734 6,021 6,861 8,307
Operating lease right-of-use assets
14,535 15,886 4,562 5,806
Other assets
12,992 12,805 13,712 13,809
Total assets
652,396 717,597 763,954 832,184
Accounts payable
5,970 9,669 12,653 18,263
Accrued expenses and other current liabilities
40,124 44,354 44,368 44,538
Deferred revenue, current portion
2,795 2,961 12,261 14,621
Total current liabilities
48,889 56,984 69,282 77,422
Operating lease liabilities, net of current portion
13,874 14,096 981 1,765
Deferred revenue, net of current portion
34,340 35,508 74,119 82,943
Other long-term liabilities
973 1,032 1,093 1,139
Total liabilities
98,076 107,620 145,475 163,269
Ordinary shares, including non-voting ordinary shares, 0.01 nominal value 163,361,109 and 159,685,229 shares authorized on march 31, 2026 and december 31, 2025, respectively 69,707,026 and 69,367,896 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
899 894 894 893
Additional paid-in capital
1,519,276 1,512,339 1,500,653 1,491,882
Accumulated other comprehensive loss
-5,279 -3,505 -3,471 -3,363
Accumulated deficit
-960,576 -899,751 -879,597 -820,497
Total shareholders' equity
554,320 609,977 618,479 668,915
Total liabilities and shareholders' equity
652,396 717,597 763,954 832,184
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$559,474K Research and developmentincentives receivable$40,917K Prepaid expenses andother current assets$18,744K Total current assets$619,135K Operating leaseright-of-use assets$14,535K Other assets$12,992K Property and equipment,net$5,734K Total assets$652,396K Total liabilities andshareholders' equity$652,396K Total shareholders'equity$554,320K Total liabilities$98,076K Accumulated deficit-$960,576K Accumulated othercomprehensive loss-$5,279K Additional paid-in capital$1,519,276K Total currentliabilities$48,889K Deferred revenue, net ofcurrent portion$34,340K Operating leaseliabilities, net of current...$13,874K Other long-termliabilities$973K Ordinary shares,including non-voting...$899K Accrued expenses andother current...$40,124K Accounts payable$5,970K Deferred revenue,current portion$2,795K

BICYCLE THERAPEUTICS PLC (BCYC)

BICYCLE THERAPEUTICS PLC (BCYC)